Dietary supplementation of krill oil attenuates inflammation and oxidative stress in experimental ulcerative colitis in rats

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 1, 2012, Pages 49-58

  Grimstad, Tore ^a,b   Bjørndal, Bodil ^c   Cacabelos, Daniel ^d   Aasprong, Ole Gunnar ^a   Janssen, Emiel A M ^a   Omdal, Roald ^a,b   Svardal, Asbjørn ^b   Hausken, Trygve ^b,c   Bohov, Pavol ^c   Portero Otin, Manuel ^d   Pamplona, Reinald ^d   Berge, Rolf K ^c  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF LLEIDA   (Spain)

Author keywords

Colitis; Diet therapy; Inflammatory bowel diseases; Omega 3 fatty acids

Indexed keywords

DEXTRAN SULFATE; EDIBLE OIL; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; KRILL OIL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROSTAGLANDIN D2; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2; PROSTAGLANDIN E3; SIRTUIN 4; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ACTIVITY; FOOD INTAKE; GENE EXPRESSION; INFLAMMATION; LIPID COMPOSITION; MALE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SHRIMP; ULCERATIVE COLITIS; WEIGHT GAIN;

ALPROSTADIL; ANIMALS; CHEMOKINE CXCL1; COLITIS, ULCERATIVE; COLON; DEXTRAN SULFATE; DIETARY SUPPLEMENTS; EUPHAUSIACEA; FATTY ACIDS, OMEGA-3; INTERLEUKIN-1BETA; MALE; ORGAN SIZE; OXIDATIVE STRESS; PPAR GAMMA; RATS; RATS, WISTAR; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84055190826     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.634025     Document Type: Article

References (44)

1. Schirbel A, Fiocchi C. Inflammatory bowel disease: established and evolving considerations on its etiopathogenesis and therapy. J Dig Dis 2010;11:266-76.
2. Aslan A, Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebocontrolled, crossover study. Am J Gastroenterol 1992;87: 432-7.
3. Stenson WF, Cort D, Rodgers J, Burakoff R, DeSchryver- Kecskemeti K, Gramlich TL, et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 1992;116: 609-14.
4. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric- coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996;334: 1557-60. (Pubitemid 26177482)
5. Belluzzi A. Polyunsaturated fatty acids (n-3 PUFAs) and inflammatory bowel disease (IBD): pathogenesis and treatment. Eur Rev Med Pharmacol Sci 2004;8:225-9. (Pubitemid 39654524)
6. MacLean CH, Mojica WA, Newberry SJ, Pencharz J, Garland RH, Tu W, et al. Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease. Am J Clin Nutr 2005;82:611-19.
7. De Ley M, de Vos R, Hommes DW, Stokkers P. Fish oil for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2007;4:CD005986.
8. Turner D, Steinhart AH, Griffiths AM. Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2007;3:CD006443.
9. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006;83: 1505S-19S.
10. Tou JC, Jaczynski J, Chen YC. Krill for human consumption: nutritional value and potential health benefits. Nutr Rev 2007;65:63-77. (Pubitemid 351804381)
11. Gaudio E, Taddei G, Vetuschi A, Sferra R, Frieri G, Ricciardi G, et al. Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig Dis Sci 1999;44:1458-75. (Pubitemid 29404313)
12. Wu D, Meydani SN. n-3 polyunsaturated fatty acids and immune function. Proc Nutr Soc 1998;57:503-9. (Pubitemid 128737120)
13. Camuesco D, Galvez J, Nieto A, Comalada M, Rodriguez- Cabezas ME, Concha A, et al. Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr 2005;135:687-94. (Pubitemid 40464089)
14. Nieto N, Torres MI, Rios A, Gil A. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J Nutr 2002;132: 11-19. (Pubitemid 34042448)
15. Vilaseca J, Salas A, Guarner F, Rodriguez R, Martinez M, Malagelada JR. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut 1990;31:539-44. (Pubitemid 20185956)
16. Barros KV, Xavier RA, Abreu GG, Martinez CA, Ribeiro ML, Gambero A, et al. Soybean and fish oil mixture increases IL-10, protects against DNA damage and decreases colonic inflammation in rats with dextran sulfate sodium (DSS) colitis. Lipids Health Dis 2010;9:68.
17. Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 2008;52:885-97.
18. Stucchi AF, Shofer S, Leeman S, Materne O, Beer E, McClung J, et al. NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol 2000;279: G1298-306.
19. Carrier J, Aghdassi E, Platt I, Cullen J, Allard JP. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther 2001;15:1989-99. (Pubitemid 34014356)
20. Blight EG, Dyer WJ. A rapid method of total lipid extraction and purification. J Biochem Physiol 1959;37:911-17.
21. Mangold HK. Aliphatic lipids in thin-layer chromatography. In: Stahl E, editor. A Laboratory Handbook, 2nd ed. Berlin, Germany: Springer; 1969:363-421.
22. Kates M. General analytical procedures. M. Dates, editor. Amsterdam: Elsevier Science Publishers; 1986.
23. Utsunomiya T, Chavali SR, Zhong WW, Forse RA. Effects of sesamin-supplemented dietary fat emulsions on the ex vivo production of lipopolysaccharide-induced prostanoids and tumor necrosis factor alpha in rats. Am J Clin Nutr 2000;72: 804-8. (Pubitemid 30667103)
24. Vigerust NF, Cacabelos D, Burri L, Berge K, Wergedahl H, Christensen B, et al. Fish oil and 3-thia fatty acid have additive effects on lipid metabolism but antagonistic effects on oxidative damage when fed to rats for 50 weeks. J Nutr Biochem; doi:10.1016/j.jnutbio.2011.08.006.
25. Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. The advanced glycation end product, Nepsilon- (carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 1996;271:9982-6.
26. Ahmed MU, Brinkmann Frye E, Degenhardt TP, Thorpe SR, Baynes JW. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 1997;324:565-70.
27. Requena JR, Chao CC, Levine RL, Stadtman ER. Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. Proc Natl Acad Sci USA 2001;98:69-74. (Pubitemid 32095865)
28. Akagawa M, Sasaki D, Ishii Y, Kurota Y, Yotsu- Yamashita M, Uchida K, et al. New method for the quantitative determination of major protein carbonyls, alpha-aminoadipic and gamma-glutamic semialdehydes: investigation of the formation mechanism and chemical nature in vitro and in vivo. Chem Res Toxicol 2006;19: 1059-65. (Pubitemid 44384836)
29. Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, et al. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest 1999;104:383-9. (Pubitemid 29534322)
30. Bassaganya-Riera J, Hontecillas R. CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Clin Nutr 2006;25:454-65. (Pubitemid 43843028)
31. Verdin E, Hirschey MD, Finley LW, Haigis MC. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci 2010;35: 669-75.
32. Sheibanie AF, Yen JH, Khayrullina T, Emig F, Zhang M, Tuma R, et al. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23→IL-17 axis. J Immunol 2007;178: 8138-47. (Pubitemid 46898086)
33. Jiang GL, Nieves A, Im WB, Old DW, Dinh DT, Wheeler L. The prevention of colitis by E Prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration. J Pharmacol Exp Ther 2007;320:22-8. (Pubitemid 46025715)
34. Sasaki S, Hirata I, Maemura K, Hamamoto N, Murano M, Toshina K, et al. Prostaglandin E2 inhibits lesion formation in dextran sodium sulphate-induced colitis in rats and reduces the levels of mucosal inflammatory cytokines. Scand J Immunol 2000;51:23-8. (Pubitemid 30074299)
35. Ajuebor MN, Singh A, Wallace JL. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. Am J Physiol Gastrointest Liver Physiol 2000;279:G238-44.
36. Hernandez Y, Sotolongo J, Breglio K, Conduah D, Chen A, Xu R, et al. The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia.BMC Gastroenterol 2010;10:82.
37. Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, Thomas LS, et al. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 2006;131: 862-77. (Pubitemid 44316821)
38. Ungaro R, Fukata M, Hsu D, Hernandez Y, Breglio K, Chen A, et al. A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol 2009;296:G1167-79.
39. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998;391:82-6. (Pubitemid 28079219)
40. Marion-Letellier R, Dechelotte P, Iacucci M, Ghosh S. Dietary modulation of peroxisome proliferator-activated receptor gamma. Gut 2009;58:586-93.
41. Ulven SM, Kirkhus B, Lamglait A, Basu S, Elind E, Haider T, et al. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids 2011;46:37-46.
42. Carnielli VP, Verlato G, Pederzini F, Luijendijk I, Boerlage A, Pedrotti D, et al. Intestinal absorption of long-chain polyunsaturated fatty acids in preterm infants fed breast milk or formula. Am J Clin Nutr 1998; 67:97-103. (Pubitemid 28037632)
43. Rezaie A, Parker RD, Abdollahi M. Oxidative stress andpathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci 2007;52:2015-21. (Pubitemid 47246507)
44. Yamagishi S, Matsui T. Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid Med Cell Longev 2010;3:101-8.